Sinopharm Group Co. Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 17,150.86 million compared to CNY 16,049.97 million a year ago.

Net income was CNY 252.36 million compared to CNY 328.8 million a year ago. Basic earnings per share from continuing operations was CNY 0.59 compared to CNY 0.77 a year ago.